Enovis Cost of Goods Sold 2010-2024 | ENOV
Enovis cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
| Enovis Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $716 |
| 2022 | $694 |
| 2021 | $649 |
| 2020 | $517 |
| 2019 | $1,926 |
| 2018 | $1,464 |
| 2017 | $1,266 |
| 2016 | $2,193 |
| 2015 | $2,363 |
| 2014 | $3,146 |
| 2013 | $2,901 |
| 2012 | $2,762 |
| 2011 | $453 |
| 2010 | $351 |
| 2009 | $339 |
| Enovis Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-09-30 | $219 |
| 2024-06-30 | $236 |
| 2024-03-31 | $218 |
| 2023-12-31 | $191 |
| 2023-09-30 | $175 |
| 2023-06-30 | $180 |
| 2023-03-31 | $171 |
| 2022-12-31 | $177 |
| 2022-09-30 | $168 |
| 2022-06-30 | $179 |
| 2022-03-31 | $170 |
| 2021-12-31 | $-177 |
| 2021-09-30 | $162 |
| 2021-06-30 | $156 |
| 2021-03-31 | $508 |
| 2020-12-31 | $-792 |
| 2020-09-30 | $462 |
| 2020-06-30 | $379 |
| 2020-03-31 | $468 |
| 2019-12-31 | $493 |
| 2019-09-30 | $478 |
| 2019-06-30 | $533 |
| 2019-03-31 | $423 |
| 2018-12-31 | $132 |
| 2018-09-30 | $353 |
| 2018-06-30 | $369 |
| 2018-03-31 | $610 |
| 2017-12-31 | $-399 |
| 2017-09-30 | $581 |
| 2017-06-30 | $590 |
| 2017-03-31 | $494 |
| 2016-12-31 | $413 |
| 2016-09-30 | $528 |
| 2016-06-30 | $656 |
| 2016-03-31 | $596 |
| 2015-12-31 | $375 |
| 2015-09-30 | $673 |
| 2015-06-30 | $697 |
| 2015-03-31 | $617 |
| 2014-12-31 | $815 |
| 2014-09-30 | $791 |
| 2014-06-30 | $811 |
| 2014-03-31 | $729 |
| 2013-12-31 | $814 |
| 2013-09-30 | $694 |
| 2013-06-30 | $736 |
| 2013-03-31 | $656 |
| 2012-12-31 | $720 |
| 2012-09-30 | $666 |
| 2012-06-30 | $731 |
| 2012-03-31 | $645 |
| 2011-12-31 | $116 |
| 2011-09-30 | $110 |
| 2011-06-30 | $122 |
| 2011-03-31 | $105 |
| 2010-12-31 | $107 |
| 2010-09-30 | $85 |
| 2010-06-30 | $80 |
| 2010-03-31 | $78 |
| 2009-12-31 | $84 |
| 2009-09-30 | $82 |
| 2009-06-30 | $85 |
| 2009-03-31 | $88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.693B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.714B | 55.57 |
| Tempus AI (TEM) | United States | $7.994B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.961B | 177.00 |
| Inspire Medical Systems (INSP) | United States | $5.693B | 177.56 |
| IRhythm Technologies (IRTC) | United States | $3.453B | 0.00 |
| Privia Health (PRVA) | United States | $2.701B | 225.10 |
| Azenta (AZTA) | United States | $2.440B | 130.24 |
| Clover Health Investments (CLOV) | United States | $2.230B | 0.00 |
| Omnicell (OMCL) | United States | $2.070B | 67.71 |
| Schrodinger (SDGR) | United States | $1.819B | 0.00 |
| 10x Genomics (TXG) | United States | $1.796B | 0.00 |
| Phreesia (PHR) | United States | $1.669B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.748B | 0.00 |
| Standard BioTools (LAB) | United States | $0.588B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.515B | 0.00 |
| TruBridge (TBRG) | United States | $0.362B | 105.43 |
| Nyxoah SA (NYXH) | Belgium | $0.354B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
| Pulmonx (LUNG) | United States | $0.230B | 0.00 |
| American Well (AMWL) | United States | $0.169B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.096B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.069B | 0.00 |
| CareCloud (CCLD) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |